# Hydroxycarbamide: UK patient leaflet, explained

Source: patient information leaflet for Hydroxycarbamide Medac 500mg Capsule  Hard (licence PL 11587/0019), approved by the MHRA. Leaflet dated 2026-10-23. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/bd7f486df6cb879a0d4e1e261092e6644e849038

Canonical page: https://pestle.health/uk/hydroxycarbamide

## What is hydroxycarbamide for?
This medicine belongs to a group of medicines used in certain blood diseases and interferes with the growth of cancer cells. It is prescribed for tumours of the bone marrow: chronic myeloid leukaemia, essential thrombocythaemia and polycythaemia vera.

## Key facts
- You need close supervision, with blood tests before and during treatment (normally once a week) to check your blood cells, kidneys and liver.
- Skin cancer has been reported with long-term use, so protect your skin from the sun and check your skin regularly.
- There is a risk of harm to an unborn baby: do not take it in pregnancy unless your doctor specifically prescribes it, and use effective contraception.
- Swallow the capsules whole, handle them with care (use gloves or wash your hands afterwards) and drink plenty of fluids during treatment.
- Contact your doctor straight away if you get fever, cough or breathing problems.

## Who should not take hydroxycarbamide?
- if you are allergic to hydroxycarbamide or any of the other ingredients of this medicine
- if your blood cell count is too low

## Check with a doctor or pharmacist first if
- Treatment needs extensive supervision with regular blood tests
- Tell your doctor if you have ever had gout
- Tell your doctor if you have folic acid deficiency
- Tell your doctor if you have kidney and/or liver problems before treatment starts
- Anaemia before or during treatment: red blood cells may be replaced when needed; if haemolytic anaemia is detected your doctor will stop treatment
- Secondary leukaemia may develop with long-term treatment (how far this is due to the disease or the treatment is unknown)
- Skin cancer has been reported with long-term use: protect your skin from the sun and inspect it regularly during and after treatment
- Leg ulcers may occur and your doctor will decide if you should continue
- Persistent eye problems such as redness and pain, sensitivity to light and/or worsening vision (possible limbal stem cell deficiency): see a doctor promptly
- If you have diabetes and use a continuous glucose monitor (CGM): hydroxycarbamide may cause falsely high sensor glucose readings, which could lead to too much insulin and low blood sugar; ask the prescriber of your CGM if it is safe to use
- Previous or current similar medicines or irradiation therapy can make side effects more frequent and severe
- Taking it with NRTI HIV medicines (such as didanosine, stavudine) can increase the risk of side effects of the NRTI
- Contains lactose: speak to your doctor if you have an intolerance to some sugars
- Tell your doctor if you have recently had or plan to have a vaccination
- Drink plenty of fluids during treatment
- Your ability to react may be impaired, so take care when driving or using machines

## Side effects that need urgent help
- Fever, cough or breathing problems, which could be a sign of serious lung disease (frequency not known)
- High fever (>39°C) with stomach, lung, muscle, liver, skin and heart problems within 6 weeks of taking the medicine (rare)
- Persistent eye problems such as redness and pain of the eyes, sensitivity to light and/or worsening vision (frequency not known)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- Absence or low amount of sperm in semen (azoospermia or oligospermia)
- Decrease in the number of blood cells (suppressed bone marrow function)
- Low white blood cells (leukocytopenia)
- CD4 lymphocytes decreased
- Low red blood cells (anaemia)
- Low platelets (thrombocytopenia)
- Feeling sick (nausea)
- Vomiting
- Loss of appetite
- Mouth sores (stomatitis)
- Diarrhoea
- Constipation
- Abdominal pain
- Inflammation of the lining (mucositis)
- Digestion troubles (dyspepsia)
- Black tarry stools
- Blood in the stools
- In combination with certain HIV treatments: inflammation of the pancreas (pancreatitis) with stomach or abdominal pain
- Fever caused by the medicine
- Chills
- Feeling of discomfort (malaise)
- Weakness
- Loss of energy
- Skin ulcers, especially leg ulcers
- Skin eruptions in form of spots and blisters (maculopapular rash)
- Redness of the face
- Redness of hands and feet (hand-foot syndrome)
- Purple-coloured rash
- Thinning of the skin
- Darkening and wasting of nails and skin
- Itching
- Small, violet skin bumps
- Scaling of the skin
- Blackening and death of skin
- Loss of hair (alopecia)
- Temporary kidney problems with elevation of certain blood parameters like uric acid, urea and creatinine
- Difficulties in passing urine

### Common (Up to 1 in 10 people)
- Enlarged immature red blood cells (megaloblastosis)
- Skin cancer
- Increase in liver enzymes
- Inflammation of the liver (hepatitis) which causes flu-like symptoms, including tiredness, loss of appetite, fever, aching, feeling sick/being sick, pressure or pain below the right ribs, and might also include yellowing of the skin or eyes
- Problems with the flow of the bile (cholestasis), which can cause itchiness, yellow skin, very dark urine and very pale stools
- Neurological disturbances: headache
- Neurological disturbances: dizziness
- Neurological disturbances: drowsiness
- Neurological disturbances: disorientation
- Neurological disturbances: hallucinations
- Neurological disturbances: fits
- Acute and chronic lung reactions with changes in lung tissue seen in x-ray and shortness of breath, as well as fever in acute reactions and dry cough in chronic reactions
- In combination with certain HIV treatments: numbness and tingling or pain in arms and legs (peripheral neuropathy)
- In combination with certain HIV treatments: abdominal pain, nausea or vomiting or yellow skin (hepatotoxicity)

### Uncommon (Up to 1 in 100 people)
- Thick and scaly patches of skin (actinic keratosis)
- High levels of break down product of red blood cells (bilirubin) in blood

### Rare (Up to 1 in 1,000 people)
- Allergic reactions
- Metabolic complications due to break-down products of cancer cells (tumour lysis syndrome)
- Skin ulceration with severe infection
- High fever (>39°C) with stomach, lung, muscle, liver, skin and heart problems within 6 weeks of taking the medicine

### Very rare (Up to 1 in 10,000 people)
- Inflammation of the skin causing red scaly patches and possibly occurring together with pain in the joints
- Reduced kidney function

### Not known (The leaflet says how often is not known)
- High blood levels of potassium which can cause abnormal heart rhythm
- Fever, cough or breathing problems, this could be a sign of serious lung disease
- Allergic inflammation of air sacs
- Haemolytic anaemia
- Dry skin
- Deep sores in the tissue of the digestive tract
- Persistent eye problems such as redness and pain of the eyes, sensitivity to light, and/or worsening vision (limbal stem cell deficiency)

### Not stated (The leaflet gives no frequency)
- Low blood levels of sodium which can cause tiredness and confusion, muscle twitching, fits or coma (observed in post-marketing surveillance)
- Secondary leukaemia (blood cancer) with long-term treatment

## Other medicines the leaflet mentions
- Any other medicines you are taking, have recently taken or might take
- Similar medicines or irradiation therapy, current or previous
- NRTI (nucleoside reverse transcriptase inhibitors) used for HIV, such as didanosine and stavudine
- Indinavir (HIV medicine)
- Any recent or planned vaccination

## Pregnancy and breastfeeding
There is a risk of harmful effects on the developing baby, so do not take this medicine during pregnancy unless your doctor specifically prescribes it, and use effective contraception before, during and for six months after treatment. Do not breast-feed while taking it because the active substance passes into breast milk.

## How to take it
- Take it exactly as your doctor has told you; the starting dose depends on your condition and is then adjusted according to your blood cell counts.
- Usual starting doses per day: chronic myeloid leukaemia 40 mg/kg bodyweight; polycythaemia vera 15 to 20 mg/kg (then adjusted to 1 to 2 capsules, 500 to 1000 mg); essential thrombocythaemia 15 mg/kg.
- Elderly patients may be more sensitive and may need a lower dose.
- Swallow the capsules whole and do not let them break up in the mouth. Use gloves or wash your hands thoroughly after handling them; pregnant women should avoid handling the capsules.
- If you miss a dose, do not take a double dose; continue as prescribed, and if you miss several doses contact your doctor.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
